| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/21/2002 | WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme |
| 03/21/2002 | WO2002022169A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 03/21/2002 | WO2002022155A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2002022045A1 Implant with access channels |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001085963A3 Modification of gene expression in transgenic plants |
| 03/21/2002 | WO2001078504A3 Novel warming method of cryopreserved specimens |
| 03/21/2002 | WO2001077303A3 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001068854A3 Fibroblast growth factor-like molecules and uses thereof |
| 03/21/2002 | WO2001068818A3 Hcv ns2/3 fragments and uses thereof |
| 03/21/2002 | WO2001064923A3 Vire2-mediated trans-membrane delivery systems |
| 03/21/2002 | WO2001064837A3 β NETRIN AND USES THEREOF |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062725A3 Methods and compositions for inhibiting angiogenesis |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001051510A3 G-csf conjugates |
| 03/21/2002 | WO2001047952A3 Insecticidal proteins from bacillus thuringiensis |
| 03/21/2002 | WO2001032840A3 Hair transplantation |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | US20020035737 Cloning pigs using donor nuclei from differentiated cells |
| 03/21/2002 | US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035733 Congenic animal models of non-insulin dependent diabetes mellitus |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035245 Recombinant vanadium haloperoxidases and their uses |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020034820 Sebocytes, sebocyte-cell line and uses thereof |
| 03/21/2002 | US20020034819 Generating differentiated aggregates; obtain sample, incubate in propagation broth, recover generated tissues |
| 03/21/2002 | US20020034813 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 03/21/2002 | US20020034812 Caspase homologue |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034796 Electroactive materials for stimulation of biological activity of stem cells |
| 03/21/2002 | US20020034790 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034771 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 03/21/2002 | US20020034770 Modulators of cyclin dependent kinases; for use in the treatment of cancer; antitumor agents |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034728 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 03/21/2002 | US20020034724 Methods to selectively inactivate microorganisms in biological compositions |
| 03/21/2002 | US20020034723 Matrix and at least one peptide free synthetic lateral chain covalently bonded to matrix and containing at least two amino groups whose nitrogen atoms are at least 2.6 Angstrom removed from one another |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034517 Dendritic cell stimulatory factor |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034504 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/21/2002 | US20020034502 Retroviral vectors |
| 03/21/2002 | US20020034500 Regulatory T cells; methods |
| 03/21/2002 | US20020034499 Nutrient medium which can be used as a culture medium for epidermal cells and applications |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422762A1 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422597A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421303A1 Novel compounds |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/20/2002 | EP1188827A1 Processes for the fusion of dendritic cells with tumor cells and media for such processes |
| 03/20/2002 | EP1188825A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/20/2002 | EP1188824A2 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 03/20/2002 | EP1188821A1 Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187921A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187909A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds |